The hOCT1 and ABCB1 Polymorphisms Don't Condition the Efficacy and Toxicity of Nilotinib As First-Line Treatment: An Italian Multicentric Experience

Galimberti, S; Bucelli, C; Arrigoni, E; Barate, C; Grassi, S; Ricci, F; Guerrini, F; Ciabatti, E; Fava, C; D'Avolio, A; Fontanelli, G; Cambrin, Gr; Isidori, A; Loscocco, F; Caocci, G; Greco, M; Bocchia, M; Aprile, L; Gozzini, A; Scappini, B; Cattaneo, D; La Nasa, G; Bosi, A; Petrini, M; Leoni, P; Danesi, R; Saglio, G; Visani, G; Cortellezzi, A; Scortechini, Ar; Iurlo, A; Di Paolo, A